Phase-3 trial of Bharat Biotech’s Covaxin begins in State
Coronavirus Update, COVID-19, News

Phase-3 trial of Bharat Biotech’s Covaxin begins in State

December 3, 2020

Bengaluru: Stating that Covaxin trials will be successful in the State, Health and Medical Education Minister Dr. K. Sudhakar said Karnataka is fully prepared for the distribution of COVID-19 vaccine.

He was speaking here after the launch of the 3rd phase clinical trials of Bharat Biotech’s Covaxin at Vydehi Institute of Medical Science and Research Centre here yesterday. Chief Minister B.S. Yediyurappa joined the event via video-conference.

Dr. Sudhakar said it was a matter of pride that clinical trials were happening at 25 centres of 12 States including Karnataka across the country. As many as 26,000 people were being administered with vaccination of which, 1,600 to 1,800 people belonged to Karnataka. People should be wary of rumours and misinformation during this trial period, he added.

Free treatment

On side effects of vaccine, the Minister said that around 15 to 20 percent Indian companies were developing vaccination globally. There may be side effects of vaccination. Experts were observing it carefully and there was no need for panic at this stage. The State Government had earmarked Rs. 300 crore for vaccine trials. Free treatment was being given to Covid patients. As many as 1.25 lakh tests were conducted daily and 1.2 crore free COVID testing has been done so far, the Minister said.

Vaccine Distribution Centres

He said Karnataka was fully prepared for vaccine distribution. A total of 29,451 vaccine distribution centres have been identified and 10,008 trained staff were ready. As many as 2,855 cold storage centres were available for the storage of vaccines. Regional centres were being set up in Bengaluru, Shivamogga and Ballari. Healthcare workers would be given vaccination in the first phase followed by frontline warriors, people above 50 years and people of with comorbidities.

READ ALSO  Mysuru touches 100 COVID-19 cases

PM Modi’s Government has reserved Rs. 900 crore for vaccine research. Modi himself visited and inspected the research centres in Pune, Ahmedabad and Hyderabad, he said.

2 COMMENTS ON THIS POST To “Phase-3 trial of Bharat Biotech’s Covaxin begins in State”

  1. Hey Covid19! says:

    Life of ordinary Indians such as the vegetable vendor is cheap, and they will get this vaccination if they fork out Rs 2000. For the VIPs such as Modi, his chums, Yedi and his chums and politicians in power, the imported Pfizer vaccine, which Modi has lied for the Indian poor and gets free. He has even invited the British PM for that Republic Day tamasha, to get the vaccine approved in Britain. Nothing but the best will do for him and his colleagues! As for the poor there is always God, but even the darshan is restricted to VIPs! Wonderful 70+ year Republic Day in country which is infected with large corrupt practices, nepotism, political leaders’ lives are more precious that the poor , No vaccine for this!
    Jai Hind!!

  2. Howdy, Modi! says:

    Modi, with his long beard, looking like Osama Bin Laden, addressing all parties says this:
    “”Prices of the vaccine is of key importance. The government is in talks with states to determine prices and costs of vaccines and inoculation,”
    So, the vaccination is not free, as he has prattled to the world leaders, pointing out the India’s poor. The cost for the poor street vegetable vendor, will be many times the officlal cost. The Indian doctors, who somewhere in another thread is praised by one of their kind, is out make plenty of money based on poor patients’ suffering and distress.
    Well done India after 70+ years of independence.


Mysuru’s favorite and largest circulated English evening daily has kept the citizens of Mysuru informed and entertained since 1978. Over the past 45 years, Star of Mysore has been the newspaper that Mysureans reach for every evening to know about the happenings in Mysuru city. The newspaper has feature rich articles and dedicated pages targeted at readers across the demographic spectrum of Mysuru city. With a readership of over 2,50,000 Star of Mysore has been the best connection between it’s readers and their leaders; between advertisers and customers; between Mysuru and Mysureans.


Academy News Papers Private Limited, Publishers, Star of Mysore & Mysuru Mithra, 15-C, Industrial ‘A’ Layout, Bannimantap, Mysuru-570015. Phone no. – 0821 249 6520

To advertise on Star of Mysore, email us at

Online Edition: [email protected]
Print Editon: [email protected]
For News/Press Release: [email protected]